Watertown, Mass.-based Respiratory Motion (RM) Inc., a manufacturer of noninvasive respiratory volume-monitoring technologies, announces the launch of the digital ExSpiron2Xi—its first product launch since 2017.

“The new digital platform of enhanced monitoring falls in line with RM’s commitment to rapidly innovate leading-edge products and services that establish accurate and safe new product,” company officials say. RM’s “new ExSpiron2Xi enhances the previously existing standalone technology to healthcare providers across the globe in decision making when involving respiratory status.”

Laura Piccinini, CEO of Respiratory Motion, also spoke out about the product launch, commenting, “The Proven Respiratory Sentry has a new formula, and I am proud of announcing the launch of our ExSpiron2Xi, [which is] unique, accurate, and [gives users confidence.”